Cure My Disease

Don't miss your cure!

 Log in / Sign up

New clues in blood and spinal fluid could unlock early Alzheimer's detection

NCT ID NCT07353502

Recruiting now Knowledge-focused Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether certain substances in blood and spinal fluid can help detect Alzheimer's disease early. Researchers will measure specific molecules linked to brain cell communication problems seen in early Alzheimer's. They will study 40 older adults with Alzheimer's to see if these substances relate to memory loss and brain shrinkage. The goal is to find a simple way to diagnose the disease sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood or spinal fluid test to catch Alzheimer's earlier, when treatments might work better.
What could go wrong
This is a small, early-stage observational study, not a treatment trial. The findings may not lead to a reliable test or apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE BIOMARKER IN EARLY DIAGNOSIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine

    RECRUITING

    Yiwu, Zhejiang, 322000, China

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.